SCHEMBL4472724

SCHEMBL4472724

Cc1cc(-c2ccc(Cl)c(C(=O)NC(O)C3CCCCCC3)c2)nn1CC(=O)N1CCCC1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 7/20 0.47
CNR2 P34972 4/20 0.42
CRHR1 P34998 3/20 0.42
KAT6A Q92794 2/20 0.40
KAT8 Q9H7Z6 2/20 0.40
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
KAT5 Q92993 1/20 0.37
CRHR2 Q13324 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CNR1 P21554 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2182575 0.92 P2RX7 (0.47) P2RX7CNR2CRHR1KAT6AKAT8
SCHEMBL4460902 0.90 P2RX7 (0.50) P2RX7CNR2CRHR1KAT6AKAT8
SCHEMBL4466795 0.89 P2RX7 (0.51) P2RX7CNR2CRHR1KAT6AKAT8
SCHEMBL4469159 0.88 P2RX7 (0.49) P2RX7CNR2CRHR1KAT6AKAT8
SCHEMBL2180488 0.86 P2RX7 (0.50) P2RX7CNR2CRHR1KAT6AKAT8
SCHEMBL2182071 0.85 P2RX7 (0.53) P2RX7CNR2CRHR1KAT6AKAT8
SCHEMBL5212562 0.85 P2RX7 (0.46) P2RX7CNR2CRHR1KAT6AKAT8
SCHEMBL5212460 0.85 P2RX7 (0.56) P2RX7CNR2CRHR1KAT6AKAT8
SCHEMBL2180237 0.85 P2RX7 (0.46) P2RX7CNR2CRHR1KAT6AKAT8
SCHEMBL5571545 0.85 P2RX7 (0.52) P2RX7CNR2CRHR1KAT6AKAT8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1837330-B1 Benzamide inhibitors of the P2X7 receptor PFIZER PROD INC (US) 2012-10-24 EP claimed
EP-1837330-A1 Benzamide inhibitors of the P2X7 receptor Pfizer Products Inc. (US) 2007-09-26 EP claimed
US-20070142329-A1 Benzamide Inhibitors of the P2X7 Receptor PFIZER INC. 2007-06-21 US claimed
EP-1837330-B1 Benzamide inhibitors of the P2X7 receptor PFIZER PROD INC (US) 2012-10-24 EP disclosed
US-7553972-B2 Benzamide inhibitors of the P2X7 receptor PFIZER, INC. (US) 2009-06-30 US disclosed
EP-1837330-A1 Benzamide inhibitors of the P2X7 receptor Pfizer Products Inc. (US) 2007-09-26 EP disclosed
US-20070142329-A1 Benzamide Inhibitors of the P2X7 Receptor PFIZER INC. 2007-06-21 US disclosed
US-7186742-B2 Benzamide inhibitors of the P2X7 receptor PFIZER INC (US) 2007-03-06 US disclosed
EP-1626962-B1 BENZAMIDE INHIBITORS OF THE P2X7 RECEPTOR PFIZER PROD INC (US) 2007-02-28 EP disclosed
US-20050009900-A1 Benzamide inhibitors of the P2X7 receptor ZOETIS LLC 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142329-A1 Benzamide Inhibitors of the P2X7 Receptor IL1R1, P2RY1, P2RX1 P2RX7 7/4885CNR2 117/4885CRHR1 430/4885
US-20050009900-A1 Benzamide inhibitors of the P2X7 receptor IL1R1, P2RY1, P2RX1 P2RX7 7/4885CNR2 117/4885CRHR1 430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.